In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dana-Farber has 1,500 pieces of art on its main campus in Boston’s Longwood Medical Area and its satellite sites to help reduce anxiety for patients and their families.

Tags: PatientSupport

  • Dr. Eliezer Van Allen led a study showing why some of the newest cancer therapies don’t work on everyone.

Tags: DrugResistance, Immunotherapy

  • A study led by researchers at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center showed a high-fat diet may increase an individual’s risk for colon cancer.

Tags: ColonCancer, Nutrition

  • A study led by Dr. Christopher Lathan shows that cancer patients with limited finances are more likely to have increased symptoms and poorer quality of life.

Tags: ColonCancer, LungCancer

  • Dr. Richard Stone talks about a patient who benefited from Profile, Dana-Farber's precision medicine program.  Dr. Barrett Rollins and Dr. Matthew Meyerson also comment.

  • Dr. Laurie H. Glimcher is picked as next Chief Executive Officer of Dana-Farber Cancer Institute.

Tags: Appointments

  • Dana-Farber Cancer Institute has appointed Dr. Laurie Glimcher as its new CEO, the first female CEO in the organization’s 69-year history.

Tags: Appointments

  • Dr. Levi Garraway commented on a promising cancer drug that researchers can use in knocking out cancer cells.

Tags: TargetedTherapy

  • Dana-Farber and Lifespan have signed a letter of intent to form a partnership that aims to improve cancer treatment, research and teaching.

Tags: Partnerships

  • Dr. Ann Partridge led a study showing testing for BRCA1 and BRCA2 gene mutations, which significantly increase a woman’s risk of getting breast cancer and ovarian cancer, is on the rise among women ages 40 and under who’ve been diagnosed with breast cancer.

Tags: BreastCancer

Showing 31-40 of 668 items